Technical Analysis for NEPT - Neptune Technologies & Bioresources Inc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.20 | -45.95% | -0.17 |
Earnings due: Mar 28
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
New 52 Week Closing Low | Bearish | 0.00% | |
Volume Surge | Other | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% |
Get this analysis on your stocks daily!
- Earnings date: 03/28/2024
Neptune Technologies & Bioresources Inc Description
Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. It produces marine-derived omega-3 polyunsaturated fatty acids, including Neptune Krill Oil (NKO), a dietary supplement for heart, joint, women, and brain health; ECOKRILL Oil (EKO), a krill product; and Neptune Krill Aquatein (NKA), a protein ingredient used in the production of nursing feed for young animals. The company also develops active pharmaceutical ingredients for cardiovascular and neurological diseases; and prescription drugs and medical foods for the safe and effective management of cognitive, behavioral, and neurodegenerative disorders. Neptune Technologies & Bioressources sells its products in Canada, the United States, France, Belgium, Australia, Japan, and other countries. The company was founded in 1925 and is headquartered in Laval, Canada.
Classification
Sector: Consumer Defensive
Industry: Packaged Foods
Keywords: Biotechnology Acid Dietary Supplement Lipid Biomass Nutrition Pharmaceutical Industries Prescription Drugs Active Pharmaceutical Ingredients Nutraceutical Fatty Acids Neurodegenerative Disorders Medical Food Urological Diseases Omega 3 Fatty Acid Polyunsaturated Fat Saturated Fat
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 28.0 |
52 Week Low | 0.19 |
Average Volume | 442,791 |
200-Day Moving Average | 3.09 |
50-Day Moving Average | 0.46 |
20-Day Moving Average | 0.39 |
10-Day Moving Average | 0.37 |
Average True Range | 0.09 |
RSI (14) | 31.03 |
ADX | 22.98 |
+DI | 22.03 |
-DI | 28.17 |
Chandelier Exit (Long, 3 ATRs) | 0.37 |
Chandelier Exit (Short, 3 ATRs) | 0.47 |
Upper Bollinger Bands | 0.50 |
Lower Bollinger Band | 0.27 |
Percent B (%b) | -0.3 |
BandWidth | 60.38 |
MACD Line | -0.03 |
MACD Signal Line | -0.03 |
MACD Histogram | -0.0075 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.32 | ||||
Resistance 3 (R3) | 0.33 | 0.30 | 0.30 | ||
Resistance 2 (R2) | 0.30 | 0.27 | 0.29 | 0.29 | |
Resistance 1 (R1) | 0.25 | 0.25 | 0.23 | 0.24 | 0.29 |
Pivot Point | 0.22 | 0.22 | 0.21 | 0.21 | 0.22 |
Support 1 (S1) | 0.17 | 0.19 | 0.16 | 0.16 | 0.11 |
Support 2 (S2) | 0.14 | 0.17 | 0.14 | 0.11 | |
Support 3 (S3) | 0.09 | 0.14 | 0.10 | ||
Support 4 (S4) | 0.08 |